Back to GetFilings.com




SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549


FORM 10-K

FOR ANNUAL AND TRANSITION REPORTS PURSUANT TO
SECTIONS 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

(MARK ONE)
   
x
 
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
   
FOR THE FISCAL YEAR ENDED DECEMBER 31, 2004
     
   
OR
     
o
 
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
   
FOR THE TRANSITION PERIOD FROM __________ TO __________

COMMISSION FILE NUMBER: 1-13861

MED-EMERG INTERNATIONAL INC.
(Exact Name of Registrant as Specified in Its Charter)

PROVINCE OF ONTARIO, CANADA
(State or Other Jurisdiction of Incorporation or Organization)
 
6711 Mississauga Road, Suite 404
Mississauga, Ontario, Canada
L5N 2W3
(Address of Principal Executive Offices)
(Zip Code)
 
Registrant’s telephone number, including area code:
(905) 858-1368

Securities registered or to be registered pursuant to Section 12(b) of the Act.
   
(Title of each class)
(Name of each exchange on which registered)
COMMON STOCK, NO PAR VALUE
OTC Bulletin Board
REDEEMABLE COMMON STOCK PURCHASE WARRANTS
OTC Bulletin Board

Securities registered or to be registered pursuant to Section 12(g) of the Act.
   
COMMON STOCK, NO PAR VALUE
OTC Bulletin Board
REDEEMABLE COMMON STOCK PURCHASE WARRANTS
OTC Bulletin Board
   
Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act.
NONE

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes x
No ¨

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. x

Indicate by check mark whether registrant is an accelerated filer (as defined in Exchange Act Rule 126-2).

Yes ¨
No x

The aggregate market value of the shares of common stock (based upon the closing sales price of the Company’s common stock as reported on the OTC Bulletin Board on March 31, 2005) of the registrant held by non-affiliates on December 31, 2004 was approximately $23,311,000.

As of March 31, 2005, 58,277,696 shares of the registrant’s common stock were outstanding. (All figures in US dollars unless otherwise noted.)



PART I
 
ITEM 1:
BUSINESS
 
BACKGROUND

Based in Ontario, Canada, Med Emerg International Inc (“MEII”) is an established health care solutions provider. Founded in 1983, initially to provide contract staffing of emergency room physicians and nurses, the Company has expanded to offer a wide variety of healthcare staffing solutions and medical services to governments, communities and facilities across Canada.

In these times, with the Canadian Healthcare system facing continuous challenges on several fronts, opportunities exist for a company like MEII to deliver innovative solutions within the confines of the Canada Health Act. Demand for more complex services from an ageing population, the capital and human resource requirements of new lifesaving technology and the need to retrofit existing ageing facilities all place strain on the system. The situation is exacerbated by burn-out in the workplace caused by declining enrolments in health professions and increased levels of retirement by the existing practitioners. The increasing severity of the condition now manifests itself in daily headlines announcing long waiting lists for elective surgery, shortages of family physicians and the governments struggle to keep pace with the ever increasing costs of a publicly funded, universally available healthcare system.
 
The Company currently employs staff covering 26 categories of healthcare professionals including physicians, dentists, pharmacists and nurses.

As a healthcare solutions provider, MEII in addition to its staffing business provides medical services such as chronic pain management and intravenous infusion services for pharmaceutical companies in conveniently located community-based clinics.

As a result of its many years of healthcare experience, MEII has developed a comprehensive understanding of primary care renewal, project evaluation, and healthcare human resource planning.

The recent equity investment from a group of Canadian and International investors provides MEII with an international recruiting expertise and capability in addition to its Canadian healthcare operations.
 
The Company's operations are divided into four units: Staffing Solutions, Medical Services, Government Healthcare Services and Healthcare Consulting Services.

STAFFING SOLUTIONS

Hospitals are increasingly turning to third-party experts to devise and implement improvements to the recruitment and management of their clinical staff. We provide physician staffing services to approximately 30 healthcare facilities in various provinces, including rural and urban facilities as well as tertiary care centers. In 2004 the company introduced Primary Health Care Nurse Practitioners to our mix of healthcare providers in hospitals.
 
MEII has developed a unique integrated staffing solution as a result of an approach by the Whitby Mental Health Centre to recruit primary care physicians. Reviewing the patient population, the nature of the cases being treated, and the total cost of the current system, MEII pioneered an integrated health care model combining Primary Care Physicians with Primary Care Nurse Practitioners. This was the first time a nurse practitioner function was introduced into a mental health setting. The program, now in its ninth year of operation, has received high satisfaction ratings from both staff and patients, resulting in the Whitby Mental Health Centre receiving the ACE award from the Ministry of Health for Innovation in Health Care Delivery Design. In June 2002, the Centre for Addiction and Mental Health awarded MEII a similar contract for primary care services.
 
Since 1990, the Company has been involved in the provision of healthcare services in some of the most difficult environments. The Company currently provides after hours physician coverage to 8 federal penitentiaries in Ontario, and has developed a unique delivery model in a provincial penitentiary in Nova Scotia, using Physician Assistants supported telephonically by emergency physicians.

 


In March 2005, MEII reached an understanding with a provincial pharmacist association, to create a program to provide temporary placement of pharmacists in pharmacies across the province. MEII will be responsible for the recruitment, credentialing, placement and monitoring of the pharmacists.

MEDICAL SERVICES
 
In addition to its healthcare staffing solutions, MEII provides innovative medical services directly to healthcare consumers.
 
Infusion Services
In March 2001, Med-Emerg entered into an agreement with Schering-Plough Canada to become a coordinator for the community-based infusion of Remicade™, in Ontario.  This contract capitalizes on the Company's access to clinics for the treatment of patients with disabling rheumatoid arthritis and Crohn's disease. The Company has established over 20 infusion sites to-date and delivered over 6,000 infusions in 2004. MEII is expecting continued growth for this service, as the trend seems to be to move infusion services from institution settings into community based settings.

Pain Management Services
Med-Emerg’s chronic pain management service, CPM Health Centres (“CPM”), was launched in November 2004 with the acquisition of the Scarborough Pain Clinic. A second location, in downtown Toronto, was opened in December 2004. CPM has developed a standardized approach to the treatment of chronic pain, using an integrated multi-disciplinary approach including anesthetists, ER physicians, physiotherapists and chiropractors, amongst others.

It is estimated that more than 10% of Canadians suffer from chronic pain (unexplained pain lasting more than 6 months). This equates to more than 800,000 people living in southern Ontario who would potentially access medical services for the treatment of pain. Existing facilities in the region are backlogged with waiting times of 4-6 months. Due to the large demand, existing facilities in the rural areas are backlogged with waiting times of between 4-12 months.

With the objective of reducing these waiting times, the Company has created a two-pronged approach to improving service availability to that require professional chronic pain management care. The Company developed and launched a training program specifically designed to educate emergency room physicians in chronic pain management. The first group has completed the didactic portion of the training program. Med-Emerg is now scheduling these doctors in our Toronto-area clinics to complete the clinical portion of their training.

Preliminary plans have been completed to increase the capacity and throughput of the Scarborough clinic by doubling the number of clinical pain providers and increasing the hours and days of operation of the facility. This clinic is currently receiving approximately 50 new referrals per week with a waiting time of almost three months to book initial assessment appointments. The volume of referrals will more than satisfy the increased capacity, once the clinic has been modified and the new providers are in place. 

Plans are underway to open additional sites in 2005.

GOVERNMENT HEALTHCARE SERVICES
 
In March of 2001, the Company was awarded an administrative management services contract, the largest of its kind, to provide medical staffing for military bases of the Department of National Defence (DND) across Canada. The contract had an initial period of three years ending on March 31, 2004, but the contract was amended and extended until March 31, 2005. As the service administrator, the Company recruits, credentials, schedules and pays physicians, nurses, dentists, physiotherapists and other regulated healthcare professionals as required by the local health authority resident on each base.  As of January 2005, Med-Emerg was supplying more than 750 healthcare providers to DND under this contract. The Company is paid a monthly administrative management fee by the DND that is linked to the number of providers being managed.




The primary benefit to DND from this contract is the creation of a “one stop shopping” arrangement for the military base. As part of a national organization, the Company’s recruiters source health service providers from all regions of Canada.  Because of its long-term relationships with its employees and sub-contractors, and its ability to react quickly to changing local conditions, the Company provides stability in the workforce and enhances continuity in the delivery of patient care for the DND. 

In May 2004, Public Works and Government Services Canada (PWGSC) re-tendered the Contract, which was set to expire March 31, 2005. Med-Emerg responded to the tender proposal and its bid was one of three considered by PWGSC. In December 2004 Med-Emerg learned that it was not successful in its bid to win a follow-on contract with DND. Its contractual relationship with the Canadian government for DND medical staffing services will accordingly end on March 31st, 2005.

After learning that its bid had not been successful, in January 2005 the Company launched a Cdn.$100,000,000 lawsuit against the winning bidder and a former employee of the Company.  Med-Emerg believes that the successful bidder used confidential information obtained through the hiring of a former Med-Emerg employee to win the contract, and that the former Med-Emerg employee retained by the successful bidder breached his legal obligations by disclosing financial and other information confidential to Med-Emerg.  On January 31, 2005, the Company filed a complaint with the Canadian International Trade Tribunal (CITT).  The CITT is the administrative tribunal in Canada with the jurisdiction to conduct inquiries into complaints by potential suppliers concerning procurement by the federal government departments and agencies, including DND and PWGSC. In its submission to the CITT, Med-Emerg questioned the manner in which the Government of Canada’s procurement for the DND medical staffing contract, valued at $448,810,965, was conducted, including the evaluation of its proposal submitted in response to the Request for Proposal (RFP). Specifically, Med-Emerg alleges that PWGSC:
 
 
Ø
Awarded the contract to a bidder that did not meet the mandatory requirements of the bid;
 
Ø
Introduced unpublished evaluation criteria to the evaluation process, and
 
Ø
Failed to properly apply the published evaluation criteria.
 
In filing the complaint, Med-Emerg seeks to terminate the contract award to the winning bidder, to have Med-Emerg awarded the contract, or in the alternative, to have a new bid process conducted.  In the further alternative, the Company asks that it be compensated for lost profit on the contract and the costs associated with the filing of the complaint. . The CITT accepted the complaint for inquiry on February 8, 2005.  Subsequent to the commencement of the inquiry, PWGSC filed a motion to have the complaint dismissed on the grounds that the CITT did not have jurisdiction over a health services contract. The motion was denied. The CITT has until June 15, 2005 to rule on the complaint.
 
HEALTHCARE CONSULTING
 
Over the years, MEII has developed significant experience in international and domestic healthcare consulting. Currently the Company is involved with several provincial governments, advising on a variety of issues related to primary care staffing, training and integrated service delivery models. The Company is currently working with the four Atlantic provinces (New Brunswick, Nova Scotia, PEI and New Foundland and Labrador) and has created an innovative health human resource planning tool which is focused on a needs based model as opposed to the traditional supply based design. The Atlantic project has received wide recognition in the marketplace, and it is reasonable to expect new business opportunities as a result of this. The Company was recently awarded a contract by the Canadian Nurses Association to develop the standard of practice for nurse practitioners across Canada. In addition, the Company is working on other smaller healthcare consulting projects.

FACTORS AFFECTING MEII’S BUSINESS

REGULATION OF HEALTHCARE IN CANADA
 
The provision of medical services in Canada is, for the most part, under provincial jurisdiction. Currently provincial governments are responsible for paying physicians for the provision of insured services to residents of their province. Any changes in reimbursement regulations, policies, practices, interpretations or statutes that place material limitations on reimbursement amounts or practices could adversely affect the operations of the Company, absent, or prior to, satisfactory renegotiations of contracts with clients and arrangements with contracted physicians.
 




Under a combination of statutory provisions, both federal and provincial, physicians are prohibited from billing their patients for fees in excess of those payable for services listed in the Provincial Schedule of Benefits. The Canada Health Act allows for cash contributions by the federal government in respect of insured health services provided under provincial healthcare insurance plans. In order for a province to qualify for a full cash contribution, there is a requirement that the provincial healthcare insurance plan satisfy the criteria set out in the Canada Health Act. In addition, the provincial plan must ensure that no payments are permitted in respect of insured health services that have been subject to extra billing.

Continuing budgetary constraints at both the federal and provincial level and the rapidly escalating costs of healthcare and reimbursement programs have led, and may continue to lead, to significant reductions in government and other third party reimbursements for certain medical charges. The Company's independent contracted physicians as well as the Company are subject to periodic audits by government reimbursement programs to determine the adequacy of coding procedures and reasonableness of charges.

Business corporations are legally prohibited from providing, or holding themselves out as providers of, medical care in many provinces. While the Company will seek to structure its operations to comply with the provincial laws relating to the corporate practice, given varying and uncertain interpretations of such laws, the Company could be found in non-compliance with restrictions on the corporate practice of medicine in all provinces. A determination that the Company is in violation of applicable restrictions on the practice of medicine in any province in which it operates or could operate could have a material adverse effect on the Company if the Company were unable to restructure its operations to comply with the requirements of such province.

COMPETITION
 
The Company competes with a variety of healthcare service providers. These include the following by MEII business unit:

 
Staffing Solutions: Third party staffing agencies (nursing); Small groups of physicians that provide competitive services to local hospitals (physicians)
 
Medical Services: Public hospitals; Homecare agencies; and Physician practice management companies
 
Government Healthcare Services: Regional players that provide services for only one or two regulated health professions and national staffing agencies
 
Healthcare Consulting: Independent consulting companies.

EMPLOYEES
 
As of December 2004, the Company had 495 active full-time employees, 24 were employed in administration, 10 were involved in staffing solutions, 22 were active in medical services, 3 were in the consulting division and, and 436 were employed to carry out the contract with the DND. The Company believes its relations with its employees to be good. The Company’s employees do not belong to a union and there is no collective bargaining agreement covering the employees. The Company also has approximately 560 contractors engaged on a full and part-time basis, of which about 300 are involved in the DND contract.

ITEM 2:
PROPERTIES
 
Our principal executive office is located at 6711 Mississauga Road, Suite 404, Mississauga, Ontario. The principal office occupies approximately 9,000 square feet of space under lease agreements that expire December 31, 2007, at an average annual rental rate of approximately $156,000 (CDN$202,000). We believe that our current office space is adequate for our future needs.

ITEM 3:
LEGAL PROCEEDINGS

Claims have been made against the Company for general damages for breach of contract and in tort. A claim for approximately $423,000 has been made against the company for wrongful termination of a person working on a third party contract. The Company’s lawyers are of the opinion that the amount claimed grossly exceeds what a court would award in light of the current law. Another claim of approximately $ 1,833,000 plus interest and costs has been made against the Company, for amongst other things, defamation and economic loss in regards to a healthcare provider working on a third-party contract. The Company’s lawyers are of the opinion that the amounts claimed are excessive and that if there is any liability on the Company, then the third-party contractor should be responsible to indemnify the Company. Since the Company’s lawyers are of the opinion that these claims are unlikely to succeed, no provision has been made in respect thereof in these consolidated financial statements.




YFMC HealthCare Inc. (“YFMC”), a wholly owned subsidiary of the Company, is in receipt of a letter from Canada Revenue Agency ("CRA") dated April 30, 2001, adjusting YFMC’s Goods and Services Tax returns for the period from December 31, 1992, to December 31, 1996. The total amount claimed by CRA for this period is $249,000. In the event that YFMC becomes liable to pay any such amount to CRA, the Company will claim an indemnity for such amount against the directors and certain named principals of YFMC pursuant to the Company’s rights under the Business Combination Agreement executed on August 10, 1999. The Company’s legal counsel has advised that CRA does not intend to pursue YFMC for these amounts.

On January 25, 2005, MEII filed a statement of claim against Calian Limited (“Calian”) and a former employee of MEII, seeking Cdn$100,000,000 in damages, in regards to the recent contract award by Public Works and Government Services Canada (“PWGSC”) to provide services to the Canadian Forces, Department of National Defence. This contract would have been an extension of a current contract which expires March 31, 2005. We have been advised that Calian intends to defend the claim.
 
On February 8, 2005, the Canadian International Trade Tribunal (“CITT”) announced that it would conduct an inquiry into the award by PWGSC, of a medical staffing contract, to Calian. MEII filed a complaint with the CITT on January 31, 2005 alleging that PWGSC:
 
 
Awarded the contract to a bidder that did not meet the mandatory requirements of the bid;
 
Introduced unpublished evaluation criteria to the evaluation process; and
 
Failed to properly apply the published evaluation criteria.
 
If the CITT determines that the complaint by MEII is valid, it could recommend that the contract award to Calian be terminated and a contract awarded to MEII, that the proposals be re-evaluated or that a new solicitation should take place, in no particular order of probability. In certain circumstances, MEII may be able to seek compensation for the lost opportunity.
 
Other than the above, the Company is not a party in any material legal proceedings.

ITEM 4:
SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

There were no matters submitted to a vote of security holders during the fourth quarter of the fiscal year ended, December 31, 2004.

PART II

ITEM 5:
MARKET FOR REGISTRANT’S COMMON EQUITY AND RELATED STOCKHOLDER MATTERS

The common shares and redeemable common stock purchase warrants are listed for trading under the symbols “MDER” and “MDERW”, respectively, on the OTC Bulletin Board. From February 12, 1998 to April 16, 2001 the Company’s common shares and redeemable common stock purchase warrants were listed on the NASDAQ Small Cap Market. Since April 16, 2001, the Company’s common shares have been listed on the OTC Bulletin Board.

The following table sets forth the range of high and low sales prices from First Quarter of 2003:

   
COMMON SHARES
 
   
HIGH
 
LOW
 
Fourth Quarter, 2004
 
$
.55
 
$
.40
 
Third Quarter, 2004
 
$
.57
 
$
.32
 
Second Quarter, 2004
 
$
.65
 
$
.34
 
First Quarter, 2004
 
$
.69
 
$
.33
 
Fourth Quarter, 2003
 
$
.58
 
$
.29
 
Third Quarter, 2003
 
$
.57
 
$
.37
 
Second Quarter, 2003
 
$
.68
 
$
.40
 
First Quarter, 2003
 
$
.77
 
$
.53
 




The Company has never paid or declared cash or stock dividends on its common stock. The payment of cash dividends, if any, is at the discretion of the Board of Directors and will depend upon the Company’s earnings, capital requirements, financial condition and other relevant factors. The Company intends, for the foreseeable future, to retain any future earnings for use in its business.

In early 2004, 5,092 shares of common stock were issued to an investor pursuant to the acquisition of YMFC Healthcare Inc. on November 4, 1999 by MEII.
 
Effective June 15, 2004, the Company issued 39,360,272 common shares as part of an equity financing (the “Financing”). As a condition of the Financing, Preferred Shares, 50% of which were indirectly held by Dr. Zacharias, the CEO of MEII, were converted into 9,348,000 common shares and preferred share dividends, in the amount of $579,582, were forgiven. The preferred shares were redeemable in 2006, for common shares then valued at $4,500,000. In addition to issuing the common shares, MEII also issued, anti-dilution warrants (the “New Warrants”) to purchase common shares of MEII at prices of either $0.50 per common share or $1.00 per common share. The exercise of the New Warrants is directly tied to the exercise of existing options and warrants at $0.50 per common share and $1.00 per common share that are currently outstanding. The exercise of the New Warrants is intended to allow the new investors and former preferred shareholder to maintain their pro rata share of their equity position.
 
During the first quarter of 2005 the terms of the 1,437,500 common stock purchase warrants issued in February 1998 were amended, extending the expiry of these warrants from February 11, 2005 to February 11, 2006. MEII has also amended the terms of the warrants to provide that if the common stock of MEII, closes at $.70 or greater for thirty consecutive trading days, MEII has the right to redeem the Warrants at $.01 per Warrant upon ten days prior notice.












ITEM 6:
SELECTED FINANCIAL DATA

The following selected consolidated financial data of the Company is qualified by reference to and should be read in conjunction with the consolidated financial statements, related notes thereto, other financial data, and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” included elsewhere herein.

   
US $
 
   
YEAR ENDED DECEMBER 31,
 
   
2004
 
2003
 
2002
 
Statement of Operations Data:
                   
    Revenue
   
48,447,687
   
54,335,558
   
37,428,043
 
    Physician fees and other direct costs
   
43,693,380
   
49,217,416
   
34,382,752
 
    Gross profit
   
4,754,307
   
5,118,142
   
3,045,291
 
    Operating expenses before under noted items
   
4,810,341
   
4,678,665
   
2,704,529
 
    Depreciation and amortization
   
182,399
   
120,924
   
102,345
 
    Other expenses
   
1,102,772
   
1,730,587
   
827,336
 
     
6,095,512
   
6,530,176
   
3,634,210
 
    Loss before income taxes
   
(1,341,205
)
 
(1,412,034
)
 
(588,919
)
    Income taxes (recovery)
   
0
   
(2,458
)
 
0
 
    Minority interest
   
0
   
(2,095
)
 
(2,211
)
    Discontinued operations
   
0
   
(167,169
)
 
(16,956
)
    Net loss
   
(1,341,205
)
 
(1,574,650
)
 
(603,664
)
    Preferred share dividends
   
(34,173
)